# Gadofosveset for Axillary Staging in Breast Cancer Patients

> **NCT01437865** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Gadofosveset contrast agent enhanced MRI Axilla

## Key facts

- **NCT ID:** NCT01437865
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437865, "Gadofosveset for Axillary Staging in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01437865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*